Trademark: 88822399
Status Date
Tuesday, January 5, 2021
Registration Number
6236954
Registration Date
Tuesday, January 5, 2021
Filing Date
Thursday, March 5, 2020
Published for Opposition
Tuesday, October 20, 2020
5 Pharmaceutical and veterinary preparations, namely, biological and biochemical preparations in form of antibodies, antibody derivatives, binding proteins and peptides for medical or veterinary diagnostic purposes; biological and biochemical preparations in form of bifunctional or multifunctional proteins with binding affinity to immune cells, in particular with binding affinity to T cells and natural killer (NK) cells, in particular for the subsequent targeting of cancer cells; biological and biochemical preparations for diagnostic and therapeutic use, in particular in form of antibodies, antibody derivatives, binding proteins and peptides; biological and biochemical preparations in form of antibodies, antibody derivatives, binding proteins and peptides for use within the framework of experimental and medical or veterinary assays
1 Biological and biochemical preparations, in particular in form of antibodies, antibody derivatives, binding proteins and peptides for scientific laboratory and experimentation purposes, in particular for conducting experimental assays, other than for medical or veterinary purposes
44 Medical services, in particular in the field of immunotherapy, in particular in the field of immuno-oncology; medical services in the field of virology; medical services in the field of antiinfectives; medical services in the field of neurodegenerative diseases; medical services in the field of autoimmune diseases; in particular all of the aforesaid services related to the use of antibodies, antibody derivatives, binding proteins and peptides; medical services in the field of immunotherapy by means of activating or modulating innate and adaptive immunity, in particular in the field of immuno-oncology
42 Scientific and technological services, namely, research and design in the field of immuno-therapy, in particular in the field of immuno-oncology; scientific and technological services, namely, research and design in the field of virology; scientific and technological services, namely, research and design in the field of antiinfectives; scientific and technological services, namely, research and design in the field of neurodegenerative diseases; scientific and technological services, namely, research and design in the field of autoimmune diseases; in particular all of the aforesaid services related to the use of antibodies, antibody derivatives, binding proteins and peptides; scientific and technological services, namely, research and design in the field of immunotherapy by means of activating or modulating innate and adaptive immunity, in particular in the field of immune-oncology; industrial research in the field of immuno-oncology
Oct 6, 2023
Teas Change Of Correspondence Received
Oct 6, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 6, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 6, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 6, 2023
Teas Change Of Owner Address Received
Jan 5, 2021
Registered-Principal Register
Oct 20, 2020
Official Gazette Publication Confirmation E-Mailed
Oct 20, 2020
Published For Opposition
Sep 30, 2020
Notification Of Notice Of Publication E-Mailed
Sep 11, 2020
Approved For Pub - Principal Register
Sep 11, 2020
Examiner's Amendment Entered
Sep 11, 2020
Notification Of Examiners Amendment E-Mailed
Sep 11, 2020
Examiners Amendment E-Mailed
Sep 11, 2020
Examiners Amendment -Written
Sep 8, 2020
Previous Allowance Count Withdrawn
Sep 1, 2020
Withdrawn From Pub - Og Review Query
Aug 18, 2020
Electronic Record Review Complete
Aug 14, 2020
On Hold - Electronic Record Review Required
Aug 11, 2020
Electronic Record Review Complete
Aug 7, 2020
On Hold - Electronic Record Review Required
Aug 6, 2020
Approved For Pub - Principal Register
Aug 3, 2020
Teas/Email Correspondence Entered
Aug 3, 2020
Correspondence Received In Law Office
Jul 31, 2020
Assigned To Lie
Jul 17, 2020
Teas Response To Office Action Received
Jun 3, 2020
Notification Of Non-Final Action E-Mailed
Jun 3, 2020
Non-Final Action E-Mailed
Jun 3, 2020
Non-Final Action Written
May 26, 2020
Assigned To Examiner
Mar 11, 2020
New Application Office Supplied Data Entered
Mar 9, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
